February 11, 2026-

Highlights from the fourth quarter

• Complete income rose to $105.7 billion, a rise of 8.2% in comparison with final 12 months
• GAAP diluted earnings per share of $2.30 and adjusted earnings per share of $1.09

Highlights of the complete 12 months

• Complete revenues rose to a file excessive of $402.1 billion, up 7.8% from final 12 months
• GAAP diluted earnings per share of $1.39 and adjusted earnings per share of $6.75
• Generated money circulate from operations of $10.6 billion

Operational highlights

• CVS Pharmacy^® has efficiently accomplished the transition to cost-based reimbursement for its Business, Third-Get together Low cost, Medicare and Medicaid companies.
• Etna^® continues to enhance the expertise for healthcare professionals and their sufferers, with greater than 95% of all eligible prior authorizations authorized inside 24 hours, with many accomplished instantly.
• Healthcare model^® shut out 2025 with important buyer wins and robust retention, offering momentum for 2026.

Steering for the complete 12 months 2026

• Up to date money circulate from working steering from a minimal of $10.0 billion to a minimal of $9.0 billion
• Confirmed GAAP earnings per share steering of $5.94 to $6.14
• Confirmed adjusted EPS steering from $7.00 to $7.20

Proceed studying